Pharma

Your Article Summary

See Latest Articles

BARACLUDE Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
Bristol Myers-Squibb Company, 11/02/09

Bristol–Myers Squibb announced 48–week data from an ongoing study of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. The new BARACLUDE data were presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09

AMA meeting: Nap time mandate for on-call residents rejected
American Medical News , 11/25/09

AMA meeting: Delegate vote refines AMA stance on system reform
American Medical News , 11/25/09

 See all of Conferences/Meetings

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Huntington Hill Installs Toshiba Aquilion Premium CT
Imaging Economics, 11/25/09

Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09

 See all of Medical Devices/Products